Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Not Confirmed
Not Confirmed
03-07 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Industry Trade Show
Not Confirmed
03-07 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
04 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/04/2857500/0/en/EnteroBiotix-Completes-27m-Financing-Round-to-Advance-Clinical-Trials.html
03 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/03/2856635/0/en/EnteroBiotix-Initiates-Phase-2-Study-of-EBX-102-02-in-Patients-with-Irritable-Bowel-Syndrome-IBS.html
01 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/01/2821719/0/en/EnteroBiotix-Strengthens-its-Executive-Team-Appoints-COO-and-CFO.html
17 Jul 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/07/17/2705236/0/en/EnteroBiotix-appoints-Elmar-Schnee-as-Executive-Chairman.html
28 Mar 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/03/28/2635376/0/en/EnteroBiotix-Initiates-Phase-2-study-of-microbiome-drug-EBX-102-in-liver-cirrhosis-and-hepatic-encephalopathy.html
11 Nov 2022
// PHARMATIMES
https://www.pharmatimes.com/news/enterobiotix_announces_partnership_with_imperial_college_london_1480617
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?